Article info
PDFTherapeutics/Prevention
Randomised controlled trial
Trimethoprim-sulfamethoxazole monotherapy should not be used for treatment of severe methicillin-resistant Staphylococcus aureus infections
- Correspondence to : Professor Stephan Harbarth, Infection Control Program, Geneva University Hospitals and Medical School, Geneva 14 CH-1211, Switzerland; stephan.harbarth{at}hcuge.ch
Citation
Trimethoprim-sulfamethoxazole monotherapy should not be used for treatment of severe methicillin-resistant Staphylococcus aureus infections
Publication history
- First published July 8, 2015.
Online issue publication
September 08, 2019
Article Versions
- Previous version (8 September 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions